L. Reade Fahs - 06 Mar 2026 Form 4 Insider Report for National Vision Holdings, Inc. (EYE)

Reporting relationship: Executive Chairman, Director
Issuer ticker: EYE
Reported as of: 06 Mar 2026
Net transaction value: -$345,217
SEC form: 4
Accepted by SEC: 09 Mar 2026, 16:19:18 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jared Brandman, as Attorney-in-Fact

Key filing fact

L. Reade Fahs filed Form 4 for National Vision Holdings, Inc. (EYE) on 09 Mar 2026.

Key facts

This page summarizes L. Reade Fahs's Form 4 filing for National Vision Holdings, Inc. (EYE).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Mar 2026, 16:19.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: -$345,217.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001181253 Primary reporting owner

FAHS L READE

Relationship: Executive Chairman, Director
Address: C/O NATIONAL VISION HOLDINGS, INC.,, 2435 COMMERCE AVENUE, BLDG. 2200, DULUTH
Signature: /s/ Jared Brandman, as Attorney-in-Fact
Signature date: 09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EYE transaction

Common Stock

Options Exercise

Transaction value
Shares: +54,824
Change %: +8.2%
Price
Shares after: 726,900
Date: 06 Mar 2026
Ownership: Direct
Footnotes: F1

EYE transaction

Common Stock

Tax liability

Transaction value
Shares: -24,419
Change %: -3.4%
Price: $27.90^*
Shares after: 702,481
Date: 06 Mar 2026
Ownership: Direct
Footnotes: F2

EYE transaction

Common Stock

Sale

Transaction value: $224,838
Shares: -7,601
Change %: -1.1%
Price: $29.58
Shares after: 694,880
Date: 06 Mar 2026
Ownership: Direct
Footnotes: F3, F4

EYE transaction

Common Stock

Sale

Transaction value: $120,379
Shares: -4,071
Change %: -1.1%
Price: $29.57
Shares after: 359,359
Date: 06 Mar 2026
Ownership: Held by Trust
Footnotes: F3, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EYE transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -54,824
Change %: -28%
Price: $0.000000^*
Shares after: 137,971
Date: 06 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 54,824
Exercise price
Footnotes: F1, F6

EYE transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +71,685
Change %: +52%
Price: $0.000000^*
Shares after: 209,656
Date: 06 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 71,685
Exercise price
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Each restricted stock unit converts into common stock on a one-for-one basis.

Footnote F2

Reflects payment of tax liability by withholding securities incident to vesting of restricted stock units.

Footnote F3

This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 4, 2025.

Footnote F4

Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.71. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Footnote F5

Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.70. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Footnote F6

On March 7, 2025, the reporting person was granted 164,474 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Footnote F7

One-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026.